Thrivent Financial for Lutherans’s Prelude Therapeutics PRLD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q1
Sell
-12,594
Closed -$157K 2571
2021
Q4
$157K Buy
+12,594
New +$157K ﹤0.01% 2432